Raptor Pharma (RPTP) Enters Into Conviva Commercialization Agreement with Uni Pharma
Raptor Pharmaceutical Corp. (Nasdaq: RPTP), announced that it has entered into an exclusive agreement with Uni Pharma Co., Ltd. to commercialize Convivia, Raptor's proprietary oral formulation of 4-methylpyrazole ("4-MP"), in Taiwan. Convivia is designed to reduce systemic acetaldehyde exposure and related symptoms in liver enzyme aldehyde...
Get Alerted When News Hits On This Stock - FREE!